Back

Highlights from Transforming Cardiac Amyloidosis Care: Diagnosis, Disparities, and Multidisciplinary Solutions

Cardiac amyloidosis remains a significantly underdiagnosed condition with rising prevalence, particularly among certain populations where health disparities contribute to delayed diagnosis and suboptimal outcomes. Many clinicians across multiple specialties encounter manifestations of systemic amyloidosis but may lack the integrated knowledge needed for timely recognition and appropriate referral. This comprehensive program brings together leading experts across cardiology, hematology, neurology, orthopedics, genetics, and advanced imaging to address critical challenges in care delivery, examine health disparities, and explore innovative diagnostic and therapeutic approaches. Through keynote presentations, expert-led sessions, and interactive panel discussions, participants will gain practical insights into improving patient outcomes across the full spectrum of cardiac amyloidosis care.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1.5 credits
  • Commercial Support
  • Released
    May 13, 2026
  • Last day to claim credit
    May 14, 2027 7 months left